Stockreport

Novo Study Shows Monthly Hemophilia Drug Reduced Bleeding [BNN Bloomberg (Canada)]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Both weekly and monthly dosing with the compound, Mim8, reduced bleeding compared with no prophylaxis and with trial participants' own previous experience with other dr [Read more]